Heather Minto, MD
Pediatric Allergy/Immunology · Akron, OHNPI 1073807624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $977, 2.8 times the $355 reported in 2019.
Across 139 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$660
- AstraZeneca$478
- CSL Behring$394
- Sanofi$372
- Novartis$162
- Amgen$155
- plus $778 from 16 others
What the payments were for
- Food & beverage$2,91997%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 31 | $660 |
| AstraZeneca | 23 | $478 |
| CSL Behring | 18 | $394 |
| Sanofi | 12 | $372 |
| Novartis | 8 | $162 |
| Amgen | 7 | $155 |
| Kaleo, Inc. | 9 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| Pharming Healthcare, Inc. | 4 | $77 |
| Genentech USA, Inc. | 3 | $73 |
| GSK | 4 | $71 |
| Grifols USA, LLC | 3 | $70 |
| Biocryst US Sales Co., LLC | 2 | $49 |
| Kedrion Biopharma, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Optinose US, Inc. | 2 | $27 |
| Greer Laboratories, Inc. | 1 | $27 |
| Alk-abello, Inc | 1 | $18 |
| Pfizer | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Bio Products Laboratory USA, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$2,999 in reported general payments places this provider in the 65th percentile of 42 pediatric allergy/immunology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 19 | $277 |
Paid to pharmacies, not to this prescriber.
Other pediatric allergy/immunology in Akron
- Rajeev KishoreAkron$54
- Melvin BergerCleveland$288K
- Marc RothenbergCincinnati$126K
- Brian SchroerCleveland$48K
- Mitchell GraysonColumbus$32K
- Benjamin PrinceColumbus$26K
- David StukusDelaware$23K
- Peter MustilloColumbus$7K
- Patricia FulkersonCincinnati$7K
- Amal AssaadCincinnati$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.